BioSpace News Archive

Feb. 26, 2020 13:30 UTC Recommends Stockholders Vote “FOR” Proposed Merger with Tarveda SAN DIEGO--( BUSINESS WIRE )-- Organovo Holdings, Inc. (“Organovo”) (NASDAQ: ONVO) today announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission and has mailed these materials and a letter to its stockholders in connection with the company’s Special Meeting to be held on March 26, 2020. Stockholders of record as of February 14, 2020 will be

Los Angeles-based Evielab has launched and patented the industry’s first CBD/CBG solid sublingual pearl. Originally developed in France, Evie pearls measure just .15 inches and deliver 5 mg of the highest quality CBD and CBG.

James Schlueter, President, Effective Health Systems, (www.effectivehealthsystems.com) announced the appointment of Chris Costantino as Chief Technology Officer.

Swittons, a P360 company, has launched the first fully customizable IoT powered solution for pharmaceutical commercial organizations and physicians.

Jvion, the leader in clinical artificial intelligence (AI) for preventing avoidable patient harm, today announced the expansion of their executive team after a year of rapid growth.

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, announced today that its nutraceutical division AXIM® Wellness has launched a brand new cannabinoid-based chewing gum product, Hole-In-One Gum.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has elected president and chief executive officer Marc N. Casper, 51, as chairman, effective immediately

Foldax® announced today that Tria LifePolymer™ heart valve technology was honored with The Best Innovation Award at the 2020 Cardiovascular Research Technologies (CRT) meeting in National Harbor, MD.

Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived biopharmaceutical company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2019, with the U.S. Securities and Exchange Commission (the “SEC”).

The Mollie Biggane Melanoma Foundation and the AIM at Melanoma Foundation have partnered to create and produce “What is Ocular Melanoma?” This free brochure illustrates the locations within the eye where the disease occurs, describes symptoms, and presents risk factors.